Zevenbergen Capital Investments’s Colgate-Palmolive CL Stock Holding History

Zevenbergen Capital Investments’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,020	Closed	-$372K	–	80
2017 Q2	$372K	Buy	5,020 +310	+7%	+$23K	0.02%	74
2017 Q1	$345K	Buy	4,710 +500	+12%	+$35K	0.02%	78
2016 Q4	$276K	Sell	4,210 -1,200	-22%	-$82.3K	0.01%	77
2016 Q3	$401K	Buy	5,410 +700	+15%	+$51.7K	0.02%	75
2016 Q2	$345K	Buy	4,710 +650	+16%	+$46.3K	0.02%	67
2016 Q1	$287K	Buy	4,060 +50	+1%	+$3.33K	0.01%	70
2015 Q4	$267K	Buy	+4,010	New	+$267K	0.01%	72
2015 Q2	–	Sell	-2,950	Closed	-$205K	–	72
2015 Q1	$205K	Sell	2,950 -100	-3%	-$6.91K	0.01%	70
2014 Q4	$211K	Buy	+3,050	New	+$206K	0.01%	80

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Zevenbergen Capital Investments's CL Position: Q3 2017 in Review

Zevenbergen Capital Investments sold out of Colgate-Palmolive (CL) in Q3 2017, closing a stake of 5,020 shares — an estimated $372K sold.

Zevenbergen Capital Investments first reported a position in CL in Q4 2014 and held it in 9 quarters. The position peaked at $401K in Q3 2016. 1,357 funds tracked by Wall St. Rank hold CL as of Q3 2017.

Zevenbergen Capital Investments reported no remaining Colgate-Palmolive position as of Q3 2017 after selling out during the quarter.
Zevenbergen Capital Investments sold 5,020 Colgate-Palmolive shares in Q3 2017, an estimated $372K.
Zevenbergen Capital Investments first reported a position in Colgate-Palmolive in Q4 2014 and held it in 9 quarters.
Zevenbergen Capital Investments's Colgate-Palmolive position peaked at $401K in Q3 2016.
1,357 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2017.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2017, filed 9 Nov 2017.